14^th Euro Breast Cancer and Therapeutics

Explore how genomic profiling, molecular diagnostics, and biomarker-driven approaches are transforming breast cancer management. Discussions will focus on BRCA mutations, HER2-low disease, multigene assays, circulating tumor DNA, and precision treatment strategies that enable personalized care and improved therapeutic outcomes.

Discover the latest breakthroughs in immunotherapy and targeted therapies, including immune checkpoint inhibitors, antibody-drug conjugates, PARP inhibitors, CDK4/6 inhibitors, novel HER2-targeted agents, and combination therapies designed to overcome resistance and improve survival.

This session examines advances in managing triple-negative breast cancer through molecular profiling, immunotherapy, targeted therapies, antibody-drug conjugates, and innovative clinical trials aimed at improving outcomes in this aggressive subtype.

Learn about the latest developments in endocrine therapy, selective estrogen receptor degraders (SERDs), CDK4/6 inhibitors, PI3K inhibitors, resistance mechanisms, and personalized treatment approaches for hormone receptor-positive breast cancer.

Explore the rapidly evolving therapeutic landscape for HER2-positive and HER2-low breast cancers, including antibody-drug conjugates, tyrosine kinase inhibitors, emerging HER2-targeted therapies, and strategies to overcome treatment resistance.

This session focuses on advances in breast-conserving surgery, oncoplastic procedures, reconstructive techniques, sentinel lymph node biopsy, robotic-assisted surgery, and personalized surgical planning to optimize both oncological and cosmetic outcomes.

Discover the latest innovations in radiation therapy, including hypofractionated radiotherapy, proton therapy, adaptive radiation techniques, image-guided treatment, and combination strategies that maximize effectiveness while minimizing toxicity.

This session addresses the unique clinical and psychosocial challenges faced by younger women, including fertility preservation, hereditary breast cancer syndromes, genetic counseling, pregnancy-associated breast cancer, survivorship, and supportive care.

Gain insights into the latest systemic therapies, precision medicine, supportive care, symptom management, and multidisciplinary approaches that improve both survival and quality of life for patients with metastatic breast cancer.

This session explores lifestyle interventions, genetic counseling, chemoprevention, risk prediction models, preventive surgery, and public health strategies designed to reduce breast cancer incidence and promote early intervention.

Explore the growing role of artificial intelligence, digital pathology, radiomics, telemedicine, wearable technologies, and predictive analytics in enhancing diagnosis, treatment planning, patient monitoring, and clinical decision-making.

Learn about comprehensive survivorship care, rehabilitation, mental health support, nutrition, exercise, lymphedema management, and interventions that improve long-term quality of life for breast cancer survivors.

This session highlights the latest advances in drug discovery, translational research, adaptive clinical trial designs, biomarker-driven studies, and regulatory pathways that accelerate the development of innovative breast cancer therapies.

Aligned with the conference theme, this session explores international collaborations, global research partnerships, healthcare policies, and strategies to reduce disparities in breast cancer screening, diagnosis, treatment, and access to high-quality care worldwide.